Alcohol dependence, also known as alcohol use disorder (AUD), is a chronic condition characterised by the inability to control alcohol consumption despite negative consequences (American Psychiatric Association, 2013). For individuals struggling with AUD, the journey to sobriety can be challenging, and many benefit from comprehensive treatment approaches. Medication-assisted treatment (MAT) has emerged as an effective approach to supporting sobriety by using specific medications that help reduce cravings and prevent relapse (Anton, 2008). This article explores the role of medication in preventing alcohol consumption, discusses the types of medications available, and examines how these treatments work in conjunction with therapy and lifestyle changes to support long-term recovery.

Keywords: Medication for alcohol dependence, Alcohol use disorder (AUD) treatment, Medication-assisted treatment (MAT) for alcohol, Preventing alcohol consumption with medication, Naltrexone for alcohol cravings, Acamprosate and alcohol abstinence, Disulfiram and alcohol aversion, Cravings and alcohol treatment, Benefits of MAT for alcohol, Alcohol relapse prevention

Medication-assisted treatment for alcohol dependence involves the use of FDA-approved medications to help reduce cravings, block the rewarding effects of alcohol, or create adverse reactions to drinking. MAT is typically used alongside behavioural therapy and support groups as part of a comprehensive treatment program (Kranzler & Soyka, 2018). The primary goal of MAT is to help individuals maintain sobriety and reduce the risk of relapse.

MAT is particularly beneficial for individuals who have not been successful with abstinence-based methods alone or who experience intense cravings that make it challenging to avoid alcohol. Research has shown that MAT can significantly improve treatment outcomes by supporting patients in managing both physical and psychological triggers associated with alcohol consumption (Litten et al., 2016).

Tip: Medication-assisted treatment is most effective when combined with counselling, support networks, and lifestyle changes tailored to each individual’s needs.

Several medications are available to support individuals in reducing or ceasing alcohol consumption. Each medication works differently, targeting specific pathways in the brain to prevent alcohol intake. Common medications used in MAT for alcohol dependence include:

• Naltrexone: Naltrexone is an opioid receptor antagonist that blocks the euphoric and rewarding effects of alcohol. By reducing the pleasurable sensations associated with drinking, naltrexone helps to lower the motivation to consume alcohol (O’Malley et al., 1992). It can be taken as an oral tablet or as an extended-release injection (Vivitrol) administered once a month, making it a versatile option for individuals in treatment.
• Acamprosate (Campral): Acamprosate works by stabilising chemical signals in the brain that may be disrupted by prolonged alcohol use. It reduces cravings and withdrawal symptoms, helping individuals maintain abstinence from alcohol (Mason et al., 2006). Acamprosate is particularly effective for individuals who have already stopped drinking and want to avoid relapse.
• Disulfiram (Antabuse): Disulfiram works by interfering with the body’s ability to metabolise alcohol. When an individual consumes alcohol while taking disulfiram, they experience unpleasant reactions, such as nausea, vomiting, and headache. This deterrent effect helps discourage alcohol consumption by creating an association between drinking and negative physical effects (Fuller & Gordis, 2004).

Tip: Understanding the different mechanisms of these medications can help individuals and healthcare providers select the most appropriate treatment based on the patient’s unique needs and drinking patterns.

Each medication used in MAT for alcohol dependence functions differently, but they all work to support sobriety by reducing cravings, managing withdrawal symptoms, or creating an aversive response to alcohol.

• Reducing Cravings and Withdrawal Symptoms: Naltrexone and acamprosate reduce cravings by affecting neurotransmitter systems associated with pleasure and relaxation (Koob & Volkow, 2016). For instance, naltrexone blocks opioid receptors in the brain, which helps reduce the rewarding effects of alcohol consumption. Acamprosate, on the other hand, works by restoring the balance of neurotransmitters, making it easier for individuals to manage stress without alcohol.
• Creating Aversion to Alcohol: Disulfiram creates a strong physical deterrent by making alcohol consumption highly unpleasant. This medication is particularly effective for individuals who are motivated to remain abstinent but struggle with impulse control (Fuller & Gordis, 2004). By inducing aversive reactions, disulfiram helps prevent individuals from drinking and reinforces their commitment to sobriety.

Research indicates that individuals who adhere to MAT are less likely to experience relapse, as these medications help reduce the psychological and physiological challenges that often lead to alcohol consumption (Anton, 2008).

Tip: MAT not only aids in reducing the urge to drink but also supports individuals in managing withdrawal symptoms, making it easier to maintain long-term sobriety.

One of the key benefits of MAT is its effectiveness in reducing relapse rates among individuals with alcohol dependence. Studies have shown that medications like naltrexone and acamprosate can significantly improve abstinence rates compared to placebo treatments (Litten et al., 2016). For instance, a study by Anton et al. (2006) found that individuals receiving naltrexone treatment reported fewer days of heavy drinking and higher rates of sustained abstinence.

The use of MAT is also associated with improved psychological well-being, as the reduction in cravings allows individuals to focus on recovery goals without being overwhelmed by urges to drink. By reducing the risk of relapse, MAT supports long-term recovery and helps individuals regain control over their lives, relationships, and mental health.

Tip: MAT can be an essential component of a relapse prevention plan, particularly for individuals who have struggled with maintaining sobriety using other methods.

While MAT provides significant support for managing physical cravings and triggers, it is most effective when used as part of a comprehensive treatment plan that includes counselling and behavioural therapy. Cognitive-behavioural therapy (CBT), motivational enhancement therapy (MET), and group support programs, such as Alcoholics Anonymous (AA), complement MAT by addressing the underlying psychological and social factors that contribute to alcohol use (Miller & Wilbourne, 2002).

Counselling and support groups help individuals develop coping skills, improve self-esteem, and build a support network, which are crucial elements of long-term recovery. In combination with MAT, these therapeutic approaches create a holistic support system that addresses both the physical and emotional aspects of addiction.

Tip: A multidisciplinary approach, combining MAT with therapy and peer support, enhances recovery outcomes and helps individuals build a sustainable foundation for sobriety.

Like all medications, those used in MAT for alcohol dependence can have potential side effects, which vary depending on the individual and the specific medication used. Common side effects of naltrexone include nausea, headache, and dizziness, while acamprosate may cause diarrhoea, nausea, and fatigue (Kranzler & Soyka, 2018). Disulfiram, due to its aversive reaction with alcohol, must be taken with caution, as it can cause severe discomfort if alcohol is consumed.

Healthcare providers carefully monitor individuals on MAT to manage side effects and ensure the treatment is effective. Most side effects are manageable, and the benefits of reduced alcohol consumption often outweigh these temporary discomforts. However, individuals considering MAT should discuss potential side effects and risks with their healthcare provider to make an informed decision.

Tip: Regular communication with healthcare providers can help manage side effects and ensure a safe, effective treatment experience with MAT.

Medication-assisted treatment offers a valuable approach to supporting individuals with alcohol dependence by reducing cravings, managing withdrawal symptoms, and helping prevent relapse. Medications such as naltrexone, acamprosate, and disulfiram have been shown to be effective in supporting sobriety when used in combination with counselling and other therapeutic approaches. By addressing both the physical and psychological challenges associated with alcohol dependence, MAT provides individuals with the tools they need to manage their symptoms and maintain long-term sobriety. With proper medical guidance and a commitment to comprehensive care, MAT can play a significant role in helping individuals reclaim their lives from alcohol dependence.

• American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.).
• Anton, R. F. (2008). Naltrexone for the management of alcohol dependence. New England Journal of Medicine, 359(7), pp. 715-721.
• Fuller, R. K., & Gordis, E. (2004). Does disulfiram have a role in alcoholism treatment today? Addiction, 99(1), pp. 21-24.
• Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), pp. 760-773.
• Kranzler, H. R., & Soyka, M. (2018). Diagnosis and pharmacotherapy of alcohol use disorder: A review. JAMA, 320(8), pp. 815-824.
• Litten, R. Z., Falk, D. E., Ryan, M. L., & Fertig, J. (2016). Medication for the treatment of alcohol use disorder: A brief overview. Journal of Addiction Medicine, 10(1), pp. 1-10.
• Mason, B. J., Goodman, A. M., Chabac, S., & Lehert, P. (2006). Effect of acamprosate on alcohol consumption in alcohol-dependent patients: A meta-analysis of randomized controlled trials. Psychopharmacology, 186(1), pp. 112-119.
• Miller, W. R., & Wilbourne, P. L. (2002). Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction, 97(3), pp. 265-277.
• O’Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry, 49(11), pp. 881-887.

How to get in touch

If you or your NDIS participant need immediate mental healthcare assistance, feel free to get in contact with us on 1800 NEAR ME – admin@therapynearme.com.au